Willingness to pay for a cure of low-risk melanoma patients in Germany-Reference-Cited by-同舟云学术

Willingness to pay for a cure of low-risk melanoma patients in Germany

Published:2018-05-24 Issue:5 Volume:13 Page:e0197780
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Augustin Matthias,Blome Christine,Forschner Andrea,Gutzmer Ralf,Hauschild Axel,Heinzerling Lucie,Livingstone Elisabeth,Loquai Carmen,Schadendorf Dirk,Utikal Jochen,Wagner Tobias,Wilden Sophia,Kähler Katharina C.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012;J Ferlay;European Journal of Cancer,2013

2. Final version of 2009 AJCC melanoma staging and classification;CM Balch;J Clin Oncol,2009

3. Personality is associated with health status and impact of cancer among melanoma survivors;F Mols;Eur J Cancer,2010

4. Impact of melanoma on patients' lives among 562 survivors: a Dutch population-based study;C Holterhues;Arch Dermatol,2011

5. Psychological stress and melanoma: Are we meeting our patients' psychological needs?;NA Kasparian;Clinics in Dermatology,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Relevant Costs for Organ Preservation versus Radical Resection in Locally Advanced Rectal Cancer;Cancers;2024-03-26

2. Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel;Israel Journal of Health Policy Research;2024-02-19

3. 10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?;Applied Health Economics and Health Policy;2023-05-30

4. Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review;Expert Review of Pharmacoeconomics & Outcomes Research;2023-01-24